• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Biliary Tract Cancer

Biliary Tract Cancer - 81 Studies Found

Completed : Phase I Study of Gemcitabine or S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer
: Biliary Tract Cancer
: 2011-01-03
:
  • Drug: Gemcitabine 800mg/m2 - 1

Completed : Gemcitabine/Cisplatin/S-1(GCS) Combination Therapy for Patients With Advanced Biliary Tract Cancer
: Biliary Tract Cancer
: 2011-01-03
: Drug: S-1, Gemcitabine, Cisplatin S-1 is given daily for 7 consecutive days and gemcitabine and cisplati
Active, not recruiting : Phase II Study of Gemcitabine Versus S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer
: Biliary Tract Cancer
: 2013-03-05
:
  • Drug: Gemcitabine 1000mg/m2, d

Active, not recruiting : Docetaxel and Oxaliplatin Combination With Locally Advanced or Metastatic Biliary Tract Cancer
: Biliary Tract Cancer
: 2010-10-28
: Drug: Docetaxel, Oxaliplatin 1. Treatment Schedule
Completed : Randomized Phase 2 Study With Gemcitabine Alone and Combination Therapy for Patients With Advanced Biliary Tract Cancer
: Biliary Tract Cancer
: 2006-09-22
:
  • Drug: gemcitabine 1000 milligr

Completed : Study of S-1 Oxaliplatin (SOX) for Biliary Tract Cancer (BTC) (Ampullary Adenocarcinoma)
: Biliary Tract Cancer
: 2010-08-09
: Drug: S-1 oxaliplatin S-1 (20mg, 25mg); L-OHP (50 mg)
Active, not recruiting : Oral Rehydration Therapy for Short Hydration in Chemotherapy With CDDP Plus GEM for Biliary Tract Cancer
: Biliary Tract Cancer
: 2013-08-04
:
  • Drug: Gemcitabine , Cisplatin, Oral Rehydration Solution (ORS)

Active, not recruiting : Phase II Study of FOLFOXIRI in Patients With Locally Advanced or Metastatic Biliary Tract Cancer
: Biliary Tract Cancer
: 2011-12-13
:
  • Drug: Fluorouracil 5-fluoroura

Active, not recruiting : A Phase I Study of Adjuvant Chemotherapy With GS in Biliary Tract Cancer Undergoing Resection Without Major Hepatectomy
: Biliary Tract Cancer
: 2012-09-18
: Drug: Gemcitabine, S-1 Dose of gemcitabine and S-1 and treatment schedule
Not yet recruiting : Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer
: Biliary Tract Cancer
: 2017-03-16
:
  • Drug: Varlitinib Varlitinib:30

<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.